BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25556446)

  • 21. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.
    Laohaviroj M; Chamgramol Y; Pairojkul C; Mulvenna J; Sripa B
    Asian Pac J Cancer Prev; 2016; 17(1):201-5. PubMed ID: 26838210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
    Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
    Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered Expression of Oxidative Metabolism Related Genes in Cholangiocarcinomas.
    Aukkanimart R; Boonmars T; Juasook A; Sriraj P; Boonjaraspinyo S; Wu Z; Laummuanwai P; Pairojkul C; Khuntikeo N; Rattanasuwan P
    Asian Pac J Cancer Prev; 2015; 16(14):5875-81. PubMed ID: 26320466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
    Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.
    Jongthawin J; Chusorn P; Techasen A; Loilome W; Boonmars T; Thanan R; Puapairoj A; Khuntikeo N; Tassaneeyakul W; Yongvanit P; Namwat N
    Tumour Biol; 2014 Aug; 35(8):8051-64. PubMed ID: 24839005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orphan Nuclear Receptor RORα Regulates Enzymatic Metabolism of Cerebral 24S-Hydroxycholesterol through CYP39A1 Intronic Response Element Activation.
    Matsuoka H; Katayama M; Ohishi A; Miya K; Tokunaga R; Kobayashi S; Nishimoto Y; Hirooka K; Shima A; Michihara A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
    Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
    Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
    Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
    Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.
    Thongchot S; Yongvanit P; Loilome W; Seubwai W; Phunicom K; Tassaneeyakul W; Pairojkul C; Promkotra W; Techasen A; Namwat N
    Asian Pac J Cancer Prev; 2014; 15(14):5873-8. PubMed ID: 25081716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
    Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
    Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
    Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
    Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma.
    Chuaysri C; Thuwajit P; Paupairoj A; Chau-In S; Suthiphongchai T; Thuwajit C
    Oncol Rep; 2009 Apr; 21(4):957-69. PubMed ID: 19287994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
    Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
    Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.
    Huang XY; Ke AW; Shi GM; Ding ZB; Devbhandari RP; Gu FM; Li QL; Dai Z; Zhou J; Fan J
    Cancer; 2010 Dec; 116(23):5440-51. PubMed ID: 20715158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis.
    Thanan R; Techasen A; Hou B; Jamnongkan W; Armartmuntree N; Yongvanit P; Murata M
    Biochem Biophys Res Commun; 2015 Aug; 464(1):182-8. PubMed ID: 26100205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.